Popular Drug Linked to Gastroparesis or Stomach Paralysis

National Injury Attorneys are actively investigating concerning reports related to drugs Ozempic, Wegovy, and others. There are indications that the manufacturer may not have adequately warned patients and doctors about the potential risk of gastrointestinal side effects.

According to a recent CNN report, two patients—one on Ozempic and the other on Wegovy—experienced far more than just minor stomach symptoms due to these weight loss drugs. Their stomachs were tragically paralyzed.

The aftermath of Ozempic injections left both patients seriously ill, with severe vomiting and an inability to eat. Their diagnosis revealed the severity of their condition: severe gastroparesis, or what is commonly known as “paralyzed stomachs.”

Despite mounting evidence, the maker of Ozempic, Novo Nordisk, has dismissed allegations about the drug’s safety. But with more victims coming forward, the importance of seeking justice cannot be understated. If you or someone you care about has faced adverse side effects while taking Ozempic, you might have a rightful claim to financial compensation.

National Injury Attorneys are here to help you explore your legal options and fight for the justice you deserve. Call 1-800-736-5300 or complete this 1-minute form to qualify for a claim.

What is Ozempic®?

Ozempic (semaglutide) is a prescribed drug utilized for managing type 2 diabetes, classified as a glucagon-like peptide-1 (GLP-1) receptor agonist. Its mechanism involves encouraging insulin production and diminishing glucose production in the liver, effectively aiding in the reduction of blood sugar levels.

What is Wegovy®?

Despite both Wegovy and Ozempic sharing the same active compound, Wegovy distinguishes itself by containing a significantly higher dose of semaglutide. In a notable milestone, Wegovy received FDA approval as a weight loss medication in 2021, marking the first newly approved weight loss medication in several years.

What is Saxenda®?

Saxenda®, a GLP-1 medication, contains the active compound known as liraglutide. Initially approved by the FDA in 2010 under the brand name Victoza®, liraglutide served as an adjunct therapy for managing type 2 diabetes in combination with diet and exercise. However, after promising clinical trial results, it gained separate approval in 2017 as a weight loss medication under the name Saxenda®. This approval is intended for individuals with a BMI of 30 or higher, or those with a BMI of 27 and higher who also have a metabolic health condition. It is essential to note that Saxenda® is not intended for the treatment of type 2 diabetes.

What is Rybelsus®?

Rybelsus® is an oral medication designed for adults over the age of 18 with type 2 diabetes, serving as a viable first-line option to enhance blood sugar control. It operates by emulating the actions of GLP-1, a naturally occurring hormone that triggers insulin secretion while reducing glucagon secretion from the liver. Individuals effectively stabilized on Rybelsus® tablets have the option to transition to Ozempic® subcutaneous injections.

How Does Ozempic® Affect the Body?

Novo Nordisk acknowledges that gastrointestinal (GI) events are common side effects associated with the GLP-1 class, including semaglutide, the active ingredient in Ozempic®. While most GI side effects are typically mild to moderate in severity and of short duration, GLP-1 medications are known to cause a delay in gastric emptying, as stated in the label of each GLP-1 RA medication from the company. Symptoms such as delayed gastric emptying, nausea, and vomiting are listed as potential side effects. Although Ozempic’s weight loss effects have been widely praised, the drug does have an impact on the body’s hormones. It functions by mimicking the actions of a hormone called GLP-1, which regulates insulin and prolongs the time food spends in the stomach. Ordinarily, stomach muscle contractions assist in digesting food and emptying the stomach. However, if food remains in the stomach for an extended period or the muscles slow down excessively, it can lead to significant nausea.

What to Do If Harmed by Ozempic® or Other Weight Loss Drugs?

If you suspect that you have suffered adverse side effects due to a weight loss treatment, prioritizing your well-being is essential. Seek immediate medical attention for your symptoms. Subsequently, take the necessary steps to safeguard your rights. Here are some recommended actions:

Consult an attorney: Reach out to a seasoned attorney with expertise in Ozempic® or similar weight loss drug lawsuits. They can assess your situation and provide guidance throughout the legal process.
Gather evidence: Assemble all relevant documents, such as medical records, prescriptions, and any other evidence that can support your case.
Maintain a record: Document any symptoms, side effects, or complications you have encountered as a consequence of using the weight loss drug.
Act promptly: Be aware of potential statute of limitations that might restrict the time you have to file a lawsuit. It is crucial to contact an attorney as soon as possible to ensure you meet all necessary deadlines.

When facing severe harm caused by the negligence of others, it becomes crucial to take decisive action. At National Injury Attorneys, our network of co-counsel partner attorneys has been unwaveringly fighting for the rights of victims across the nation, securing over $100 Million in damages.

Combining the personalized service of a small firm with the extensive resources of a large one, we are fully prepared to take on even the most formidable adversaries to ensure victims receive the maximum compensation they rightfully deserve for the needless suffering they have endured.

If you have been prescribed Ozempic®, Wegovy®, Mounjaro®, Rybelsus®, Saxenda®, or any other weight loss drug and are encountering adverse side effects or have concerns about the drug’s safety, do not hesitate to contact National Injury Attorneys for a free and no-obligation case evaluation. You may be eligible to pursue compensation that can help cover medical expenses and more.